Flurbiprofen STADA 슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

flurbiprofen stada

stada arzneimittel ag, nemecko - flurbiprofén - 69 - otorhinolaryngologica

Oroflurb 슬로바키아 - 슬로바키아어 - ŠÚKL (Štátny ústav pre kontrolu liečiv)

oroflurb

stada arzneimittel ag, nemecko - flurbiprofén - 69 - otorhinolaryngologica

Movymia 유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

movymia

stada arzneimittel ag - teriparatid - osteoporóza - homeostáza vápnika - movymia je indikovaná u dospelých. liečba osteoporózy u postmenopauzálnych žien a u mužov so zvýšeným rizikom zlomeniny. u žien po menopauze, preukázalo významné zníženie incidencie stavcov a iné zlomeniny stavcov, ale nie zlomenín. liečba osteoporózy spojené s trvalým systémové glukokortikoidy terapie u žien a mužov, zvýšené riziko zlomeniny.

Kinpeygo 유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

kinpeygo

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, črevné protizápalové / antiinfective agentov - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1. 5 g/gram.

Ximluci 유럽 연합 - 슬로바키아어 - EMA (European Medicines Agency)

ximluci

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiká - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).